vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and COMSCORE, INC. (SCOR). Click either name above to swap in a different company.
COMSCORE, INC. is the larger business by last-quarter revenue ($93.5M vs $47.7M, roughly 2.0× IRONWOOD PHARMACEUTICALS INC). COMSCORE, INC. runs the higher net margin — 3.2% vs -4.8%, a 8.0% gap on every dollar of revenue. On growth, COMSCORE, INC. posted the faster year-over-year revenue change (-1.5% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $2.9M). Over the past eight quarters, COMSCORE, INC.'s revenue compounded faster (3.8% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Comscore, Inc. is an American-based global media measurement and analytics company providing marketing data and analytics to enterprises, advertising agencies, brand marketers, and publishers.
IRWD vs SCOR — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $93.5M |
| Net Profit | $-2.3M | $3.0M |
| Gross Margin | — | 41.0% |
| Operating Margin | 14.3% | 7.0% |
| Net Margin | -4.8% | 3.2% |
| Revenue YoY | -47.3% | -1.5% |
| Net Profit YoY | -200.9% | -3.7% |
| EPS (diluted) | $0.01 | $9.50 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $93.5M | ||
| Q3 25 | $122.1M | $88.9M | ||
| Q2 25 | $85.2M | $89.4M | ||
| Q1 25 | $41.1M | $85.7M | ||
| Q4 24 | $90.5M | $94.9M | ||
| Q3 24 | $91.6M | $88.5M | ||
| Q2 24 | $94.4M | $85.8M | ||
| Q1 24 | $74.9M | $86.8M |
| Q4 25 | $-2.3M | $3.0M | ||
| Q3 25 | $40.1M | $453.0K | ||
| Q2 25 | $23.6M | $-9.5M | ||
| Q1 25 | $-37.4M | $-4.0M | ||
| Q4 24 | $2.3M | $3.1M | ||
| Q3 24 | $3.6M | $-60.6M | ||
| Q2 24 | $-860.0K | $-1.7M | ||
| Q1 24 | $-4.2M | $-1.1M |
| Q4 25 | — | 41.0% | ||
| Q3 25 | — | 40.6% | ||
| Q2 25 | — | 40.6% | ||
| Q1 25 | — | 39.6% | ||
| Q4 24 | — | 42.4% | ||
| Q3 24 | — | 41.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 42.3% |
| Q4 25 | 14.3% | 7.0% | ||
| Q3 25 | 61.8% | 1.9% | ||
| Q2 25 | 53.2% | -1.9% | ||
| Q1 25 | -70.7% | -2.4% | ||
| Q4 24 | 34.8% | 4.1% | ||
| Q3 24 | 28.0% | -67.4% | ||
| Q2 24 | 26.5% | -2.2% | ||
| Q1 24 | 14.7% | -2.2% |
| Q4 25 | -4.8% | 3.2% | ||
| Q3 25 | 32.8% | 0.5% | ||
| Q2 25 | 27.7% | -10.6% | ||
| Q1 25 | -90.9% | -4.7% | ||
| Q4 24 | 2.5% | 3.3% | ||
| Q3 24 | 4.0% | -68.5% | ||
| Q2 24 | -0.9% | -2.0% | ||
| Q1 24 | -5.6% | -1.2% |
| Q4 25 | $0.01 | $9.50 | ||
| Q3 25 | $0.23 | $-0.86 | ||
| Q2 25 | $0.14 | $-2.73 | ||
| Q1 25 | $-0.23 | $-1.66 | ||
| Q4 24 | $0.03 | $-0.47 | ||
| Q3 24 | $0.02 | $-12.79 | ||
| Q2 24 | $-0.01 | $-1.19 | ||
| Q1 24 | $-0.03 | $-1.08 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | $23.6M |
| Total DebtLower is stronger | — | $41.5M |
| Stockholders' EquityBook value | $-261.8M | $111.4M |
| Total Assets | $396.9M | $407.7M |
| Debt / EquityLower = less leverage | — | 0.37× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | $23.6M | ||
| Q3 25 | $140.4M | $26.7M | ||
| Q2 25 | $92.9M | $26.0M | ||
| Q1 25 | $108.5M | $31.0M | ||
| Q4 24 | $88.6M | $29.9M | ||
| Q3 24 | $88.2M | $20.0M | ||
| Q2 24 | $105.5M | $14.7M | ||
| Q1 24 | $121.5M | $18.7M |
| Q4 25 | — | $41.5M | ||
| Q3 25 | $199.5M | $41.4M | ||
| Q2 25 | $199.3M | $41.3M | ||
| Q1 25 | $199.2M | $41.3M | ||
| Q4 24 | $199.0M | $41.2M | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $111.4M | ||
| Q3 25 | $-264.2M | $-26.3M | ||
| Q2 25 | $-308.2M | $-21.7M | ||
| Q1 25 | $-334.1M | $-13.5M | ||
| Q4 24 | $-301.3M | $-8.3M | ||
| Q3 24 | $-311.3M | $-2.7M | ||
| Q2 24 | $-321.7M | $45.8M | ||
| Q1 24 | $-330.5M | $51.4M |
| Q4 25 | $396.9M | $407.7M | ||
| Q3 25 | $396.1M | $406.9M | ||
| Q2 25 | $342.9M | $415.9M | ||
| Q1 25 | $327.2M | $421.5M | ||
| Q4 24 | $350.9M | $430.2M | ||
| Q3 24 | $389.5M | $412.5M | ||
| Q2 24 | $395.6M | $474.1M | ||
| Q1 24 | $438.8M | $477.7M |
| Q4 25 | — | 0.37× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $3.2M |
| Free Cash FlowOCF − Capex | $74.6M | $2.9M |
| FCF MarginFCF / Revenue | 156.3% | 3.1% |
| Capex IntensityCapex / Revenue | 0.0% | 0.3% |
| Cash ConversionOCF / Net Profit | — | 1.07× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $21.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $3.2M | ||
| Q3 25 | $47.6M | $9.5M | ||
| Q2 25 | $-15.1M | $932.0K | ||
| Q1 25 | $20.0M | $9.1M | ||
| Q4 24 | $15.2M | $-10.0M | ||
| Q3 24 | $9.9M | $12.5M | ||
| Q2 24 | $33.5M | $8.7M | ||
| Q1 24 | $45.0M | $6.9M |
| Q4 25 | $74.6M | $2.9M | ||
| Q3 25 | $47.6M | $9.4M | ||
| Q2 25 | $-15.1M | $787.0K | ||
| Q1 25 | $19.9M | $8.7M | ||
| Q4 24 | — | $-10.3M | ||
| Q3 24 | $9.9M | $12.4M | ||
| Q2 24 | $33.4M | $8.5M | ||
| Q1 24 | $44.9M | $6.6M |
| Q4 25 | 156.3% | 3.1% | ||
| Q3 25 | 39.0% | 10.5% | ||
| Q2 25 | -17.7% | 0.9% | ||
| Q1 25 | 48.4% | 10.1% | ||
| Q4 24 | — | -10.8% | ||
| Q3 24 | 10.8% | 14.0% | ||
| Q2 24 | 35.4% | 10.0% | ||
| Q1 24 | 60.0% | 7.6% |
| Q4 25 | 0.0% | 0.3% | ||
| Q3 25 | 0.0% | 0.1% | ||
| Q2 25 | 0.0% | 0.2% | ||
| Q1 25 | 0.1% | 0.4% | ||
| Q4 24 | 0.0% | 0.2% | ||
| Q3 24 | 0.0% | 0.1% | ||
| Q2 24 | 0.1% | 0.2% | ||
| Q1 24 | 0.1% | 0.3% |
| Q4 25 | — | 1.07× | ||
| Q3 25 | 1.19× | 20.96× | ||
| Q2 25 | -0.64× | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 6.74× | -3.19× | ||
| Q3 24 | 2.71× | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
IRWD
Segment breakdown not available.
SCOR
| Transferred Over Time | $77.1M | 83% |
| Research Insight Solutions | $14.6M | 16% |
| Related Party | $2.5M | 3% |
